Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
85.06 USD | +0.61% | -0.48% | +27.46% |
Financials (USD)
Sales 2024 * | 5.31B | Sales 2025 * | 5.78B | Capitalization | 8.51B |
---|---|---|---|---|---|
Net income 2024 * | 414M | Net income 2025 * | 464M | EV / Sales 2024 * | 2.06 x |
Net Debt 2024 * | 2.42B | Net Debt 2025 * | 2.14B | EV / Sales 2025 * | 1.84 x |
P/E ratio 2024 * |
20.9
x | P/E ratio 2025 * |
18.8
x | Employees | 27,209 |
Yield 2024 * |
0.71% | Yield 2025 * |
0.71% | Free-Float | 85.64% |
Latest transcript on Encompass Health Corporation
1 day | -0.94% | ||
1 week | -1.04% | ||
Current month | +1.40% | ||
1 month | +2.53% | ||
3 months | +12.36% | ||
6 months | +27.99% | ||
Current year | +26.72% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Tarr
CEO | Chief Executive Officer | 62 | 92-12-31 |
Douglas Coltharp
DFI | Director of Finance/CFO | 62 | 10-05-05 |
Chief Tech/Sci/R&D Officer | 64 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Leslye Katz
BRD | Director/Board Member | 69 | 13-01-24 |
Chairman | 62 | 19-12-31 | |
Director/Board Member | 68 | 21-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.44% | 8 M€ | 0.00% | ||
1.39% | 2 M€ | 0.00% | ||
1.09% | 231 M€ | -1.00% | ||
1.09% | 1 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 85.04 | +0.58% | 96 605 |
24-05-23 | 84.55 | -0.94% | 340,691 |
24-05-22 | 85.35 | -0.52% | 305,227 |
24-05-21 | 85.8 | -0.36% | 254,689 |
24-05-20 | 86.11 | +0.77% | 288,277 |
Delayed Quote Nyse, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.72% | 8.51B | |
-21.30% | 15.99B | |
+3.60% | 12.47B | |
+3.65% | 11.7B | |
+3.08% | 10.31B | |
-7.43% | 7.49B | |
+5.61% | 6.69B | |
+4.83% | 6.25B | |
-3.14% | 4.33B | |
+10.50% | 4.25B |
- Stock Market
- Equities
- EHC Stock